Artículos de revistas
Carboxypeptidases A1 and A2 from the perfusate of rat mesenteric arterial bed differentially process angiotensin peptides
Fecha
2013-08-02Registro en:
PEPTIDES, NEW YORK, v. 33, n. 1, supl. 1, Part 3, pp. 67-76, JAN, 2012
0196-9781
10.1016/j.peptides.2011.12.001
Autor
Pereira, Hugo J. V.
Souza, Laura L.
Costa Neto, Claudio Miguel da
Salgado, Maria Cristina O.
Oliveira, Eduardo B.
Institución
Resumen
Here we report the isolation of carboxypeptidases A1 and A2 (CPA1 and CPA2) from the rat mesenteric arterial bed perfusate, which were found to be identical with their pancreatic counterparts. Angiotensin (Ang) I, Ang II, Ang-(1-9) and Ang-(1-12) were differentially processed by these enzymes, worthy mentioning the peculiar CPA1-catalyzed conversion of Ang II to Ang-(1-7) and the CPA2-mediated formation of Ang I from Ang-(1-12). We detected gene transcripts for CPA1 and CPA2 in mesentery and other extrapancreatic tissues, indicating that these CPAs might play a role in the renin-angiotensin system in addition to their functions as digestive enzymes. (C) 2011 Elsevier Inc. All rights reserved.
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Aerobic Exercise Training-Induced Left Ventricular Hypertrophy Involves Regulatory MicroRNAs, Decreased Angiotensin-Converting Enzyme-Angiotensin II, and Synergistic Regulation of Angiotensin-Converting Enzyme 2-Angiotensin (1-7)
FERNANDES, Tiago; HASHIMOTO, Nara Y.; MAGALHAES, Flavio C.; FERNANDES, Fernanda B.; CASARINI, Dulce E.; CARMONA, Adriana K.; KRIEGER, Jose E.; PHILLIPS, M. Ian; OLIVEIRA, Edilamar M. (LIPPINCOTT WILLIAMS & WILKINS, 2011)Aerobic exercise training leads to a physiological, nonpathological left ventricular hypertrophy; however, the underlying biochemical and molecular mechanisms of physiological left ventricular hypertrophy are unknown. The ... -
New specific angiotensin antagonists - [8-valine]-angiotensins i, [8-isoleucine]-angiotensins I, and chlorambucil-des-1-aspartic,8-valine-angiotensins I
Paiva, Antonio Cechelli de Mattos [UNIFESP]; NOUAILHE.VL; Miyamoto, M. E.; Bergsten-Mendes, Gun [UNIFESP]; Paiva, Therezinha Bandiera [UNIFESP] (Amer Chemical Soc, 1973-01-01) -
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trialsAngiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials
Meza, Nicolás; Pérez-Bracchiglione, Javier; Pérez, Ignacio; Carvajal, Cristhian; Ortiz Muñoz, Luis Eugenio; Olguín, Pablo; Rada Giacaman, Gabriel Alejandro; Madrid, Eva (2021)Objective: This living systematic review aims to provide a timely, rigorous, and continuously updated summary of the evidence available on the role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II ...